Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 885-891, November 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heidelberger, C.
Right arrow Articles by Weiss, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heidelberger, C.
Right arrow Articles by Weiss, S. M.

The Distribution of Radioactivity in Mice Following Administration of 3,4-Benzpyrene-5-C14 and 1,2,5,6-Dibenzanthracene-9,10-C14* ,{dagger}

Charles Heidelberger and S. Marguerite Weiss

( McArdle Memorial Laboratory, The Medical School, University of Wisconsin, Madison 6, Wis.)

1. Radioactivity following intravenous injections of benzpyrene-5-C14 can be recovered quantitatively. No radioactivity appears in the respiratory CO2. The compound and its metabolites are rapidly excreted into the bile, gastrointestinal tract, and feces. There is significant absorption into body fat.
2. The half-time of disappearance of radioactivity from benzpyrene-5-C14 from the site of subcutaneous injection in tricaprylin is 13/4 weeks. Excretion takes place through the feces.
3. The rate of disappearance of radioactivity from the site of a single application of benzpyrene-5-C14 has two phases, the half-times of which are approximately 12/3 days and 41/3 days.
4. These samples have been processed into the following fractions: neutral, acidic, loosely bound, and tightly bound to protein.
5. The significance of these results has been discussed.

* An abstract of part of this report appeared in Cancer Research, 11:255, 1951.

{dagger} This work was supported in part by a grant from the Wisconsin Section of the American Cancer Society.

Received 8/10/51.


This article has been cited by other articles:


Home page
ScienceHome page
H. I. HADLER, V. DARCHUN, and K. LEE
Route of Elimination of Anthracene and 9-Methylanthracene Involving Protein Binding
Science, January 11, 1957; 125(3237): 72 - 73.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.